SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011844
Filing Date
2018-05-08
Accepted
2018-05-08 16:21:27
Documents
68
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20180331.htm 10-Q 2391937
2 EX-10.1 rgnx-ex101_77.htm EX-10.1 87713
3 EX-31.1 rgnx-ex311_76.htm EX-31.1 17078
4 EX-31.2 rgnx-ex312_75.htm EX-31.2 16906
5 EX-32.1 rgnx-ex321_74.htm EX-32.1 11292
6 GRAPHIC g201805081809504431963.jpg GRAPHIC 61943
  Complete submission text file 0001564590-18-011844.txt   10064687

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgnx-20180331.xml EX-101.INS 2703758
8 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20180331.xsd EX-101.SCH 48119
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20180331_cal.xml EX-101.CAL 50558
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20180331_def.xml EX-101.DEF 214071
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20180331_lab.xml EX-101.LAB 387820
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20180331_pre.xml EX-101.PRE 340255
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 18814904
SIC: 2836 Biological Products, (No Diagnostic Substances)